PL1906938T3 - Formulacja farmaceutyczna nitrooksypochodnych NSAID - Google Patents

Formulacja farmaceutyczna nitrooksypochodnych NSAID

Info

Publication number
PL1906938T3
PL1906938T3 PL06777502T PL06777502T PL1906938T3 PL 1906938 T3 PL1906938 T3 PL 1906938T3 PL 06777502 T PL06777502 T PL 06777502T PL 06777502 T PL06777502 T PL 06777502T PL 1906938 T3 PL1906938 T3 PL 1906938T3
Authority
PL
Poland
Prior art keywords
nitrooxyderivatives
nsaids
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Application number
PL06777502T
Other languages
English (en)
Inventor
Ulla Gasslander
Christina Holmberg
Original Assignee
Nicox Science Ireland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicox Science Ireland filed Critical Nicox Science Ireland
Publication of PL1906938T3 publication Critical patent/PL1906938T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL06777502T 2005-07-26 2006-06-29 Formulacja farmaceutyczna nitrooksypochodnych NSAID PL1906938T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05106854 2005-07-26
EP06777502A EP1906938B1 (en) 2005-07-26 2006-06-29 Pharmaceutical formulation of nitrooxyderivatives of nsaids
PCT/EP2006/063672 WO2007012539A2 (en) 2005-07-26 2006-06-29 Pharmaceutical formulation of nitrooxyderivatives of nsaids

Publications (1)

Publication Number Publication Date
PL1906938T3 true PL1906938T3 (pl) 2011-05-31

Family

ID=37670077

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06777502T PL1906938T3 (pl) 2005-07-26 2006-06-29 Formulacja farmaceutyczna nitrooksypochodnych NSAID

Country Status (24)

Country Link
US (1) US8691869B2 (pl)
EP (1) EP1906938B1 (pl)
JP (1) JP5238499B2 (pl)
KR (1) KR101342910B1 (pl)
CN (1) CN101227896B (pl)
AR (1) AR055094A1 (pl)
AT (1) ATE485033T1 (pl)
AU (1) AU2006274098B2 (pl)
CA (1) CA2616508C (pl)
CY (1) CY1112023T1 (pl)
DE (1) DE602006017701D1 (pl)
DK (1) DK1906938T3 (pl)
ES (1) ES2354278T3 (pl)
HR (1) HRP20110025T1 (pl)
IL (1) IL188253A0 (pl)
MX (1) MX2008001213A (pl)
NO (1) NO20080983L (pl)
NZ (1) NZ564589A (pl)
PL (1) PL1906938T3 (pl)
PT (1) PT1906938E (pl)
RU (1) RU2406482C2 (pl)
SI (1) SI1906938T1 (pl)
WO (1) WO2007012539A2 (pl)
ZA (1) ZA200801009B (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011209757A (ja) * 2011-07-06 2011-10-20 Rohto Pharmaceutical Co Ltd コンタクトレンズケア方法及び組成物
CA2827887C (en) * 2011-08-15 2020-06-09 Research Foundation Of The City University Of New York No- and h2s-releasing compounds
WO2013130625A1 (en) * 2012-02-27 2013-09-06 Basil Rigas Phospho-ester derivatives and uses thereof
RU2657803C1 (ru) * 2017-03-21 2018-06-15 федеральное государственное бюджетное образовательное учреждение высшего образования "Алтайский государственный университет" Средство, обладающее противовоспалительным и анальгезирующим действием

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997033568A1 (en) 1996-03-12 1997-09-18 Novartis Ag Filled gelatin capsules having a reduced degree of cross-linking
TWI243672B (en) * 1999-06-01 2005-11-21 Astrazeneca Ab New use of compounds as antibacterial agents
SE0000774D0 (sv) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
SE0000773D0 (sv) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
ES2524000T3 (es) 2002-06-05 2014-12-03 Teva Czech Industries S.R.O. Reducción de la reticulación de la gelatina
MXPA05000862A (es) 2002-07-31 2005-04-19 Pharmacia Corp Forma de dosificacion farmaceutica capaz de mantener un perfil de disolucion estable tras el almacenamiento.

Also Published As

Publication number Publication date
SI1906938T1 (sl) 2011-02-28
WO2007012539A2 (en) 2007-02-01
NZ564589A (en) 2010-01-29
KR101342910B1 (ko) 2013-12-19
JP2009502850A (ja) 2009-01-29
DK1906938T3 (da) 2011-02-07
PT1906938E (pt) 2011-01-17
IL188253A0 (en) 2008-04-13
DE602006017701D1 (de) 2010-12-02
CA2616508C (en) 2015-02-24
KR20080028412A (ko) 2008-03-31
AU2006274098B2 (en) 2012-02-09
MX2008001213A (es) 2008-03-24
HK1120414A1 (en) 2009-04-03
CY1112023T1 (el) 2015-11-04
WO2007012539A3 (en) 2007-04-19
AR055094A1 (es) 2007-08-08
ATE485033T1 (de) 2010-11-15
AU2006274098A1 (en) 2007-02-01
EP1906938A2 (en) 2008-04-09
RU2406482C2 (ru) 2010-12-20
US20090203759A1 (en) 2009-08-13
NO20080983L (no) 2008-02-25
HRP20110025T1 (hr) 2011-03-31
ES2354278T3 (es) 2011-03-11
EP1906938B1 (en) 2010-10-20
JP5238499B2 (ja) 2013-07-17
RU2008104505A (ru) 2009-09-10
CN101227896A (zh) 2008-07-23
ZA200801009B (en) 2008-11-26
US8691869B2 (en) 2014-04-08
CN101227896B (zh) 2013-02-06
CA2616508A1 (en) 2007-02-01

Similar Documents

Publication Publication Date Title
IL185390A (en) A solid dosage form
IL191531A0 (en) Orally absorbed pharmaceutical formulation
ZA200801275B (en) Pharmaceutical preparation containing meloxicam
ZA200802272B (en) Novel dosage formulation
ZA200708705B (en) Pharmaceutical composition
IL189614A0 (en) Pharmaceutical compositions of telmisartan
IL188352A0 (en) Pharmaceutical compositions
PT1850664E (pt) Formulação de cápsulas
ZA200804103B (en) Pharmaceutical compositions
GB0507208D0 (en) Anti-inflammatory formulation
IL189541A0 (en) Stable solid formulation of sertindole
GB0614586D0 (en) Pharmaceutical Formulation
IL192091A0 (en) Pharmaceutical compositions
ZA200801009B (en) Pharmaceutical formulation of nitrooxyderivatives of NSAIDS
IL198160A0 (en) Pharmaceutical formulations
GB0522045D0 (en) Pharmaceutical compositions
ZA200803566B (en) Pharmaceutical compositions
GB0514259D0 (en) Pharmaceutical compositions
GB0515937D0 (en) Pharmaceutical formulation
GB0615461D0 (en) Pharmaceutical formulations
AU2005903196A0 (en) Pharmaceutical formulation
GB0514530D0 (en) Pharmaceutical agent
GB0525269D0 (en) Pharmaceutical compositions
GB0515306D0 (en) Pharmaceutical compositions
ZA200800392B (en) Pharmaceutical composition